Gp130-Dependent Astrocytic Survival Is Critical for the Control of Autoimmune Central Nervous System Inflammation-Reference-Cited by-同舟云学术

Gp130-Dependent Astrocytic Survival Is Critical for the Control of Autoimmune Central Nervous System Inflammation

Published:2011-04-22 Issue:11 Volume:186 Page:6521-6531
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Haroon Fahad,Drögemüller Katrin,Händel Ulrike,Brunn Anna,Reinhold Dirk,Nishanth Gopala,Mueller Werner,Trautwein Christian,Ernst Matthias,Deckert Martina,Schlüter Dirk

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference57 articles.

1. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis.;Tani;Am. J. Pathol.,1996

2. Transgenic Inhibition of Astroglial NF-κB Improves Functional Outcome in Experimental Autoimmune Encephalomyelitis by Suppressing Chronic Central Nervous System Inflammation

3. Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice

4. Astrocyte-Restricted Ablation of Interleukin-17-Induced Act1-Mediated Signaling Ameliorates Autoimmune Encephalomyelitis

5. The adaptor Act1 is required for interleukin 17–dependent signaling associated with autoimmune and inflammatory disease

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic modifications of inflammation in spinal cord injury;Biomedicine & Pharmacotherapy;2024-10

2. Immunopathogenesis of multiple sclerosis: molecular and cellular mechanisms and new immunotherapeutic approaches;Immunopharmacology and Immunotoxicology;2024-04-18

3. Reactive Astrocytes and Emerging Roles in Central Nervous System (CNS) Disorders;Cold Spring Harbor Perspectives in Biology;2024-02-05

4. Autoimmune Astrocytopathy;Neuroimmune Diseases;2024

5. Astrocytes in human central nervous system diseases: a frontier for new therapies;Signal Transduction and Targeted Therapy;2023-10-13